ArticleThe Journal of nutrition2025
Vascular Roads to a Healthier Brain: Lutein Moderates the Influence of Arterial Stiffness on Cognitive Function.
Article in The Journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of pistachio consumption on cognition, cardiometabolic risk factors, and life satisfaction in older adults: Protocol for a remote-based randomized controlled trial.Contemporary clinical trials · 2026Article
- Advances in Sustainable Lutein Production: Sources, Technologies, and Functional Applications.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArterial stiffness, assessed via carotid-femoral pulse wave velocity (cfPWV), is a marker of vascular aging that may contribute to cognitive decline. Serum carotenoids, with antioxidant properties, may mitigate these effects, but their role in moderating neurovascular-cognitive relationships remains unclear.
objectivesThis study examined: 1) associations between cfPWV and executive function, 2) the contribution of serum carotenoids in predicting cfPWV, and 3) whether carotenoids moderate the relationship between cfPWV and executive function.
methodsA total of 60 adults (38.6 ± 17.57 y, 70% female) provided measures of cfPWV, serum carotenoids (lycopene, lutein, zeaxanthin, β-carotene, and β-cryptoxanthin), and executive function using Flanker and Go/No-Go tasks with event-related potentials (ERPs). Linear regression and Lindeman-Merenda-Gold metrics assessed associations and relative importance, whereas moderation analyses tested carotenoid interactions with cfPWV in predicting cognitive outcomes.
resultsHigher cfPWV was associated with slower P3 peak latency during Go target trials (β = 0.35, P = 0.02) and N2 latency during No-Go target trials (β = 0.34, P = 0.03). Serum lycopene was the strongest predictor of cfPWV (relative importance = 47.7%). Serum lutein uniquely moderated the relationship between cfPWV and executive function, such that higher lutein concentrations amplified associations between arterial stiffness and slower congruent reaction time (β = 0.48, P = 0.04) and P3 congruent peak latency (β = 0.53, P = 0.04) during the Flanker task, as well as P3 peak latency during Go (β = 0.53, P = 0.04) nontarget and No-Go (β = 0.77, P = 0.001) target trials. No other carotenoids showed significant moderation effects.
conclusionsArterial stiffness impairs early-stage cognitive processing, as reflected by ERP latencies and reaction time. Lutein's selective moderation of these effects, despite lycopene's stronger association with cfPWV, suggests distinct vascular compared with neural protective mechanisms. Promoting lutein-rich diets may support neurovascular health, warranting intervention trials in at-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.